SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test sale cost 4400 AED
RET Gene Multiple Endocrine Neoplasia Type 2B Genetic Test sale cost 4400 AED RET Gene Multiple Endocrine Neoplasia Type 2B Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test sale cost 4400 AED RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test” is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the SDHD gene. Mutations in this gene are known to be associated with an increased risk of developing paraganglioma, a rare type of tumor that can occur in various parts of the body, and gastric stromal sarcoma, a form of cancer affecting the stomach’s connective tissue. The test is particularly important for individuals with a family history of these conditions, as it can provide crucial information for early detection and management. By analyzing the genetic makeup, the test helps in understanding the genetic predisposition of an individual towards these conditions, enabling personalized treatment plans and preventive measures. The cost of the test is 4400 AED, making it a valuable investment for those seeking to assess their genetic risk for these specific types of cancer. Conducted at DNA Labs UAE, this genetic test is a step forward in the realm of personalized medicine, offering insights that could significantly impact an individual’s healthcare strategy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test

At DNA Labs UAE, we offer the SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test to help individuals identify their risk for these types of tumors. This test is designed to analyze the SDHD gene for any mutations or variations that may be present.

Test Details

The SDHD gene is associated with two different types of tumors – paraganglioma and gastric stromal sarcoma. Paragangliomas are tumors that develop from the cells of the paraganglia, which are located near certain blood vessels and nerves. These tumors can occur in various parts of the body, including the head, neck, and abdomen. Gastric stromal sarcoma, on the other hand, is a tumor that arises from the connective tissue cells in the stomach.

NGS (Next-Generation Sequencing) genetic testing is used to analyze the DNA sequence of multiple genes, including the SDHD gene, to identify any mutations or variations. This type of testing is more comprehensive and efficient compared to traditional sequencing methods, as it can analyze multiple genes simultaneously.

Test Components

  • Test Name: SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by SDHD Gene Paraganglioma and Gastric Stromal Sarcoma. This will help in understanding the genetic inheritance pattern and assessing the risk for developing these tumors.

Benefits of the Test

By identifying mutations in the SDHD gene through NGS genetic testing, individuals at risk for SDHD Gene Paraganglioma and Gastric Stromal Sarcoma can be identified. This information can be used for early detection, surveillance, and management of these tumors. Furthermore, it can also assist in guiding treatment decisions, as certain targeted therapies may be more effective in individuals with specific genetic mutations.

Don’t wait until it’s too late. Take control of your health and schedule your SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test with DNA Labs UAE today!

Test Name SDHD Gene Paraganglioma and gastric stromal sarcoma Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SDHD Gene Paraganglioma and gastric stromal sarcoma NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SDHD Gene Paraganglioma and gastric stromal sarcoma NGS Genetic DNA Test gene SDHD
Test Details

SDHD gene paraganglioma and gastric stromal sarcoma are two different types of tumors that can be caused by genetic mutations in the SDHD gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can be used to identify mutations in multiple genes simultaneously.

In the case of SDHD gene paraganglioma, mutations in the SDHD gene can lead to the development of paragangliomas, which are tumors that arise from the cells of the paraganglia, a cluster of cells located near certain blood vessels and nerves. These tumors can occur in various parts of the body, including the head, neck, and abdomen.

Gastric stromal sarcoma, on the other hand, is a type of tumor that arises from the connective tissue cells in the stomach. Mutations in the SDHD gene have been implicated in the development of gastric stromal sarcoma, although the exact mechanism is not fully understood.

NGS genetic testing can be used to analyze the DNA sequence of multiple genes, including the SDHD gene, to identify any mutations or variations that may be present. This type of testing is more comprehensive and efficient compared to traditional sequencing methods, as it can analyze multiple genes simultaneously.

By identifying mutations in the SDHD gene through NGS genetic testing, individuals at risk for SDHD gene paraganglioma or gastric stromal sarcoma can be identified. This information can be used for early detection, surveillance, and management of these tumors. Additionally, it can also help guide treatment decisions, as certain targeted therapies may be more effective in individuals with specific genetic mutations.

SKU: TEST-4552 Category:

Related products